Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer

Producción científica: Articlerevisión exhaustiva

100 Citas (Scopus)

Resumen

Pulmonary inhalation chemotherapeutic drug delivery offers many advantages for lung cancer patients in comparison to conventional systemic chemotherapy. Inhalable particles are advantageous in their ability to deliver drug deep in the lung by utilizing optimally sized particles and higher local drug dose delivery. In this work, spray-dried and co-spray dried inhalable lung surfactant-mimic PEGylated lipopolymers as microparticulate/nanoparticulate dry powders containing paclitaxel were rationally designed via organic solution advanced spray drying (no water) in closed-mode from dilute concentration feed solution. Dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) with varying PEG chain length were mixed with varying amounts of paclitaxel in methanol to produce co-spray dried microparticles and nanoparticles. Scanning electron microscopy showed the spherical particle morphology of the inhalable particles. Thermal analysis and X-ray powder diffraction confirmed the retention of the phospholipid bilayer structure in the solid-state following spray drying, the degree of solid-state molecular order, and solid-state phase transition behavior. The residual water content of the particles was very low as quantified analytically Karl Fisher titration. The amount of paclitaxel loaded into the particles was quantified which indicated high encapsulation efficiencies (43-99%). Dry powder aerosol dispersion performance was measured in vitro using the Next Generation Impactor™ (NGI™) coupled with the Handihaler® dry powder inhaler device and showed mass median aerodynamic diameters in the range of 3.4-7 lm. These results demonstrate that this novel microparticulate/nanoparticulate chemotherapeutic PEGylated phospholipid dry powder inhalation aerosol platform has great potential in lung cancer drug delivery.

Idioma originalEnglish
Páginas (desde-hasta)699-711
Número de páginas13
PublicaciónEuropean Journal of Pharmaceutical Sciences
Volumen49
N.º4
DOI
EstadoPublished - 2013

Nota bibliográfica

Funding Information:
The authors gratefully acknowledge financial support from the National Cancer Institute (NCI) Grant Number R25CA153954 and a National Cancer Institute Cancer Nanotechnology Training Center (NCI-CNTC) Postdoctoral Traineeship awarded to SAM. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The authors thank Dr. Tonglei Li for XRPD and HSM access and Dr. J. Zach Hilt for ATR-FTIR access.

Financiación

The authors gratefully acknowledge financial support from the National Cancer Institute (NCI) Grant Number R25CA153954 and a National Cancer Institute Cancer Nanotechnology Training Center (NCI-CNTC) Postdoctoral Traineeship awarded to SAM. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The authors thank Dr. Tonglei Li for XRPD and HSM access and Dr. J. Zach Hilt for ATR-FTIR access.

FinanciadoresNúmero del financiador
National Cancer Institute Cancer Nanotechnology Training Center
National Childhood Cancer Registry – National Cancer InstituteR25CA153954
National Childhood Cancer Registry – National Cancer Institute

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • Pharmaceutical Science

    Huella

    Profundice en los temas de investigación de 'Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer'. En conjunto forman una huella única.

    Citar esto